Bank Of Montreal Lannett CO Inc Transaction History

Bank Of Montreal

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 01, 2023	BUY	$0.45 - $0.86 $2,431 - $4,646	5,403 Added 13.42%	45,677 $23,000
Q3 2022 Nov 10, 2022	SELL	$0.46 - $0.63 $1,788 - $2,448	-3,887 Reduced 8.8%	40,274 $23,000
Q2 2022 Aug 11, 2022	SELL	$0.47 - $0.87 $2,234 - $4,135	-4,754 Reduced 9.72%	44,161 $27,000
Q1 2022 May 12, 2022	SELL	$0.75 - $1.77 $18,015 - $42,515	-24,020 Reduced 32.93%	48,915 $42,000
Q4 2021 Feb 11, 2022	BUY	$1.56 - $2.93 $20,286 - $38,101	13,004 Added 21.7%	72,935 $124,000
Q3 2021 Nov 12, 2021	SELL	$2.91 - $4.83 $11,907 - $19,764	-4,092 Reduced 6.39%	59,931 $195,000
Q2 2021 Aug 12, 2021	BUY	$4.17 - $5.74 $266,975 - $367,492	64,023 New	64,023 $324,000

Ticker LCI
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,960,000
Market Cap $1.29M
Description
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

Stay updated on Bank Of Montreal with notifications on news.